At Stallergenes Greer, we operate to sustain growth and create value for society as a whole.
The company’s strategy is based on three pillars:
Precision medicine for better patient care
Stallergenes Greer is committed to furthering precision medicine and personalised AIT treatments to address unmet medical needs for patients with allergies.
With precision medicine, Stallergenes Greer identifies the mechanisms of allergic response to develop best in class diagnostic tools and personalised allergen immunotherapy treatments.
We are committed to delivering unparalleled patient care through our extensive product portfolio which covers all administration (subcutaneous and sublingual) routes and personalised treatment solutions which meet the needs of both individual patient-profiles and the medical community.
Investing in our people
Stallergenes Greer is driven by an entrepreneurial mindset and believe there are no limits to what we can do as a team. We invest in our people and create a learning culture so we can all reach our potential, together.
Our patients are at the heart of every decision we make and inspire us to always go further.
We are committed to building world-class competencies in science, supply and quality. Our employees are empowered to effect positive change.
A high-performance agile business model
Stallergenes Greer is a ressource efficient organisation. Our lean operating model focuses on quality and robust operation.
We build on the company’s strong foundations to seize profitable growth opportunities by developing new business in additional geographies and markets, and through external growth by seeking to add new expertise and innovation both in our core business and in related therapeutic areas.